Thrombotic thrombocytopenic purpura following allogeneic hematopoietic stem cell transplantation: a rare but fatal complication
Year: 2025
Type: article
Language: en
Topic: Complement system in diseases
Authors and affiliations:
raw_author_name: Zhixue Li
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Peng Zhao
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Haixia Fu
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Chencong Wang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Yun He
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Xiaolu Zhu
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Qiusha Huang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Jin Wu
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Yuanyuan Zhang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Fengrong Wang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Wei Han
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Chenhua Yan
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Zhidong Wang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Jun Kong
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Tingting Han
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Jingzhi Wang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Yao Chen
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Meng Lv
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Yuqian Sun
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Yuhong Chen
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Xiaodong Mo
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Xiangyu Zhao
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Yu Wang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Yingjun Chang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: Lanping Xu
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China
raw_author_name: X. Long Zheng
raw_affiliation_strings: Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA. Electronic address: xzheng2@kumc.edu
Department of Pathology and Laboratory Medicine, The University of Kansas Medical Centre, Kansas City, Kansas, U.S.A. Electronic address: xzheng2@kumc.edu
raw_author_name: Xiaojun Huang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China. Electronic address: xjhrm@medmail.com.cn
raw_author_name: Xiaohui Zhang
raw_affiliation_strings: Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China; National Clinical Research Centre for Haematologic Disease, Beijing, China; Beijing Key Laboratory of Cell and Gene Therapy for Haematologic Malignancies, Peking University, Beijing, China. Electronic address: zhangxh@bjmu.edu.cn